ArticleTherapeutic advances in respiratory disease

Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in Sweden.

Mahasin Al Shakirchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.